Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways

Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways

Multiple sclerosis (MS) is a chronic and disabling disorder of the central nervous system (CNS) characterized by neuroinflammation leading to demyelination. Recently a combination of Δ9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) extracted from Cannabis has been approved in many parts of the wo...

Full description

Bibliographic Details
Main Authors: Zinah Zamil Al-Ghezi, Kathryn Miranda, Mitzi Nagarkatti, Prakash S. Nagarkatti
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Immunology
Subjects:
multiple sclerosis
EAE
THC
CBD
CB1
CB2
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01921/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01921/full

Similar Items